Major histocompatibility complex binding
β
Alessandro Sette; Peggy Wentworth; Howard M. Grey
π
Article
π
1991
π
Elsevier Science
π
English
β 470 KB
Peptides that bind with high affinity to major histocompatibility complex molecules could represent useful tools in treating class II-associated autoimmune diseases such as rheumatoid arthritis, type I diabetes and multiple sclerosis. Although the concept has been validated in experiments with both